In summary, this study performed a comprehensive analysis of a large, population-based CRC cohort and clearly highlighted the potential roles of the methylation status of miR137 and IGFBP3 as diagnostic biomarkers in CRC patients. This evidence concerns the gene IGFBP3 and colorectal carcinoma.